{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:32:07Z","timestamp":1793277127420,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07545-7","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:18:03Z","timestamp":1792631883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epilepsy in paediatric neurofibromatosis type 1: clinical features and associated factors in a single-centre cohort"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-330X","authenticated-orcid":false,"given":"Hatice","family":"Bektas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4995-8992","authenticated-orcid":false,"given":"Nesibe Gevher","family":"Eroglu Ertu\u011frul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-3550","authenticated-orcid":false,"given":"Aysegul Nese","family":"Citak Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"7545_CR1","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3:17004","journal-title":"Nat Rev Dis Primers"},{"key":"7545_CR2","doi-asserted-by":"crossref","unstructured":"Khair AM, Falchek S, Nikam R, Kaur G. Epilepsy and Electroencephalogram Characteristics in Children with Neurofibromatosis Type 1, What We Have Learned from a Tertiary Center Five Years' Experience. Child Neurol Open 2022;9:2329048x221131445.","DOI":"10.1177\/2329048X221131445"},{"key":"7545_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","volume":"73","author":"A Pecoraro","year":"2017","unstructured":"Pecoraro A, Arehart E, Gallentine W, Radtke R, Smith E, Pizoli C et al (2017) Epilepsy in neurofibromatosis type 1. Epilepsy Behav 73:137\u2013141","journal-title":"Epilepsy Behav"},{"key":"7545_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.yebeh.2019.06.022","volume":"98","author":"E Serdaroglu","year":"2019","unstructured":"Serdaroglu E, Konuskan B, Karli Oguz K, Gurler G, Yalnizoglu D, Anlar B (2019) Epilepsy in neurofibromatosis type 1: diffuse cerebral dysfunction? Epilepsy Behav 98:6\u20139","journal-title":"Epilepsy Behav"},{"key":"7545_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246336","author":"U Sorrentino","year":"2021","unstructured":"Sorrentino U, Bellonzi S, Mozzato C, Brasson V, Toldo I, Parrozzani R et al (2021) Epilepsy in NF1: epidemiologic, genetic, and clinical features. A monocentric retrospective study in a cohort of 784 patients. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13246336","journal-title":"Cancers (Basel)"},{"key":"7545_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15212690","author":"R Kravljanac","year":"2025","unstructured":"Kravljanac R, Be\u0111ik J, Bruno I, Vu\u010deti\u0107 Tadi\u0107 B, Popovi\u0107 S, Oparnica V et al (2025) Clinical characteristics of seizures and course of epilepsy in children with neurofibromatosis type 1-a tertiary center experience in a cohort of 118 children. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics15212690","journal-title":"Diagnostics (Basel)"},{"key":"7545_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fneur.2017.00087","volume":"8","author":"CE Stafstrom","year":"2017","unstructured":"Stafstrom CE, Staedtke V, Comi AM (2017) Epilepsy mechanisms in neurocutaneous disorders: tuberous sclerosis complex, neurofibromatosis type 1, and Sturge-Weber syndrome. Front Neurol 8:87","journal-title":"Front Neurol"},{"key":"7545_CR8","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00381-020-04710-7","volume":"36","author":"P Bernardo","year":"2020","unstructured":"Bernardo P, Cinalli G, Santoro C (2020) Epilepsy in NF1: a systematic review of the literature. Childs Nerv Syst 36:2333\u20132350","journal-title":"Childs Nerv Syst"},{"key":"7545_CR9","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23:1506\u20131513","journal-title":"Genet Med"},{"key":"7545_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475\u2013482","journal-title":"Epilepsia"},{"key":"7545_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE et al (2017) Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522\u2013530","journal-title":"Epilepsia"},{"key":"7545_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069\u20131077","journal-title":"Epilepsia"},{"key":"7545_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/08830738030180050501","volume":"18","author":"R Vivarelli","year":"2003","unstructured":"Vivarelli R, Grosso S, Calabrese F, Farnetani M, Di Bartolo R, Morgese G et al (2003) Epilepsy in neurofibromatosis 1. J Child Neurol 18:338\u2013342","journal-title":"J Child Neurol"},{"key":"7545_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","volume":"20","author":"HY Hsieh","year":"2011","unstructured":"Hsieh HY, Fung HC, Wang CJ, Chin SC, Wu T (2011) Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects. Seizure 20:606\u2013611","journal-title":"Seizure"},{"key":"7545_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/088307380401900406","volume":"19","author":"A Serdaro\u011flu","year":"2004","unstructured":"Serdaro\u011flu A, Ozkan S, Aydin K, G\u00fcc\u00fcyener K, Tezcan S, Aycan S (2004) Prevalence of epilepsy in Turkish children between the ages of 0 and 16 years. J Child Neurol 19:271\u2013274","journal-title":"J Child Neurol"},{"key":"7545_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0887-8994(98)00075-7","volume":"19","author":"K Kulkantrakorn","year":"1998","unstructured":"Kulkantrakorn K, Geller TJ (1998) Seizures in neurofibromatosis 1. Pediatr Neurol 19:347\u2013350","journal-title":"Pediatr Neurol"},{"key":"7545_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pediatrneurol.2022.11.016","volume":"142","author":"R Penn","year":"2023","unstructured":"Penn R, Harrar D, Sun LR (2023) Seizures, epilepsy, and electroencephalography findings in pediatric moyamoya arteriopathy: a scoping review. Pediatr Neurol 142:95-103.e2","journal-title":"Pediatr Neurol"},{"key":"7545_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1528-1157.1993.tb00437.x","volume":"34","author":"BR Korf","year":"1993","unstructured":"Korf BR, Carrazana E, Holmes GL (1993) Patterns of seizures observed in association with neurofibromatosis 1. Epilepsia 34:616\u2013620","journal-title":"Epilepsia"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07545-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:41:57Z","timestamp":1793274117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07545-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7545"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07545-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"6 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"871"}}